Explore more publications!

Integer to Participate at Upcoming Investor Conferences

PLANO, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that members of its executive leadership team will participate in the following investor conferences in March:

  • Raymond James 47th Annual Institutional Investors Conference, 11:35 a.m. ET, March 3
  • Oppenheimer 36th Annual Healthcare MedTech & Services Conference, 12:40 p.m. ET, March 17
  • KeyBanc Capital Markets Healthcare Forum, 11:15 a.m. ET, March 18

A live webcast and replay for each event will be accessible under “News & Events” on the Investor Relations section of Integer’s website at investor.integer.net.

Learn more about Integer at www.integer.net.

About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMOs) in the world, serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. The company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.

Media Relations:
Misty Tippen
misty.tippen@integer.net
469-536-6702

Investor Relations:
Kristen Stewart
kristen.stewart@integer.net
551-337-3973


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions